β-Blockade therapy in chronic heart failure: Diastolic function and mitral regurgitation improvement by carvedilol

American Heart Journal

Volumn 139, Issue 4, 2000, Pages 596-608

  Capomolla, Soccorso ^a   Febo, Oreste ^b   Gnemmi, Marco ^b   Riccardi, Giorgio ^b   Opasich, Cristina ^b   Caporotondi, Angelo ^b   Mortara, Andrea ^b   Pinna, GianDomenico ^b   Cobelli, Franco ^b  

^a Montescano Medical Center   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLE; DISEASE COURSE; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034110740     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90036-X     Document Type: Article

References (39)

1. 1. Ohno M, Cheng C-P, Little WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 1994;89:2241-50.
2. 2. Sabbah HN, Goldestein S. Ventricular remodelling: consequences and therapy. Eur Heart J 1993;14:24-9.
3. 3. Mulieri LA, Hasenfuss G, Leavitt B, et al. Altered myocardial force-frequency relation in human heart failure. Circulation 1992;85:1743-50.
4. 4. Hansefuss G, Mulieri LA, Leavitt BJ, et al. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res 1992;70:1225-32.
5. 5. Eichhorn EJ, Bedotto JB, Malloy CR, et al. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure: improvements in hemodynamic, contractile and diastolic performance with bucindolol. Circulation 1990;82:473-83.
6. 6. Packer M, Bristow M, Cohn JN, et al for the U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
7. 7. Colucci W, Packer M, Bristow M, et al for the US Carvedilol Heart Failure Study Group. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation 1996;94:2800-6.
8. 8. Feuerstein GZ, Ruffolo RR. Carvedilol a novel vasodilating b-blocker with the potential for cardiovascular organ protection. Eur Heart J 1996;17(suppl B):24-9.
9. 9. Weyman AE, Doty WD. Left ventricle. In: Weyman AE, editor. Cross-sectional echocardiography. Philadelphia: Lea & Febiger; 1982.267-337.
10. 10. Gordon EP, Schnittger I, Fitzgerald PJ, et al. Reproducibility of left ventricular volumes by two-dimensional echocardiography. J Am Coll Cardiol 1983;2:506-13.
11. 11. Bargiggia GS, Tronconi L, Sahn DJ. A new method for quantification of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice. Circulation 1991;84:1481-9.
12. 12. Chen C, Koschyk D, Bronckhoff C, et al. Noninvasive estimation of regurgitant flow rate and volume in patients with mitral regurgitation by Doppler color mapping accelerating flow field. J Am Coll Cardiol 1993;21:374-83.
13. 13. Xie GY, Berk MR, Hixson C, et al. Quantification of mitral regurgitant volume by the color Doppler proximal isovelocity, surface area method: a clinical study. J Am Soc Echocardiogr 1995;8:48-54.
14. 14. Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988;12:426-40.
15. 15. Dubin J, Wallerson DC, Cody RJ, Devereux RB. Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination. Am Heart J 1990;120:116-23.
16. 16. Traversi E, Pozzoli M, Cioffi G, et al. Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure. Am Heart J 1996;132:809-19.
17. 17. Vonoverschelde JJ, Raphael DA, Robert AR, et al. Left ventricular filling in dilated cardiomyopathy: relation to functional class and hemodynamics. J Am Coll Cardiol 1990;15:1288-95.
18. 18. Thomas JD, Weyman AE. Echocardiographic Doppler evaluation of left ventricular diastolic function: physics and physiology. Circulation 1991;84:977-90.
19. 19. Little W, Ohno M, Kitzam DW, et al. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 1995;92:1933-9.
20. 20. Cohen G, Pietrolungo J, Thomas J, et al. A pratical guide to assessment of ventricular diastolic using Doppler echocardiography. J Am Coll Cardiol 1996;27:1753-60.
21. 21. Eichhorn E, Heesch C, Risser RC, et al. Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol. J Am Coll Cardiol 1995;25:154-62.
22. 22. Heesch C, Marcoux L, Hatfield B, et al. Hemodynamic and energetic comparison of bucindolol and metoprolol for the treatment of congestive heart failure. Am J Cardiol 1995;75:360-4.
23. 23. Gupta R, Shimoyama H, Tanimura M, et al. SRCa2+-ATPase activity and expression in ventricular myocardium of dogs with heart failure. Am J Physiol 1997;42(suppl):H12-H18.
24. 24. Eichhorn EJ, Heesch C, Hatfield B, et al. Relation of substrate utilization to end-diastolic pressure in patients with dilated cardiomyopathy [abstract]. Circulation 1993;88(suppl I):1-346.
25. 25. Cunnigham MJ, Apstein CS, Weingerg EO, et al. Influence of glucose and insulin on the exaggerated diastolic and systolic dysfunction of hypertrophied rat hearts during hypoxia . Circ. Res 1990;66:406-15.
26. 26. Eichhorn EJ, Heesch CM, Barnett JH. Effect of metoprolol on myocardial function and energetics in patients with non ischemic dilated cardiomyopathy: a randomized, double-blind placebo-controlled study. J Am Coll Cardiol 1994;24:1310-20.
27. 27. Panchal AR, Stanley W, Kerner J, et al. Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure. J Card Failure 1988;4:121-6.
28. 28. Capomolla S, Pozzoli M, Opasich C, et al. Dobutamine and nitro-prusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial and ventricular function. Am Heart J 1997;134:1089-98.
29. 29. Doughty R, Whalley GA, Gamble G, et al on behalf of the Australia-New-Zealand Heart Failure Research collaborative Group. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 1997;29:1060-6.
30. 30. Yoshikawa T, Port JD, Asano K, et al. Cardiac adrenergic receptor effects of carvedilol. Eur Heart J 1996;17(suppl B):8-10.
31. 31. Martin BJ, Valdivia H, Bunger R, et al. Pyruvate augments calcium transients and cell shortening in rat ventricular myocytes. Am J Physiol 1998;27:H8-H17.
32. 32. Janczewski AM, Spurgeon HA, Stern MD, et al. Effects of sarcoplasmic reticulum Ca2+ load an the gain function of Ca2+ release by Ca2+ current in cardiac cells. Am J Physiol 1995;268 (suppl): H916-H920.
33. 33. Yao A, Matsui H, Spitzer KW, et al. Sarcoplasmic reticulum and N+/Ca2+ exchanger function during early and late relaxation in ventricular myocites. Am J Physiol 1997;273 (suppl):H2765-H2773.
34. 34. Erdmann E. Pathophysiology of heart failure. Heart 1998;79 (suppl):S3-S5.
35. 35. Pinamonti B, Di Lenardo A, Sinagra G, et al. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiographic and hemodynamic correlation and prognostic implications. J Am Coll Cardiol 1993;22:808-15.
36. 36. Xie G, Berj M, Smith M, et al. Prognostic value of Doppler transmitral flow pattern in patients with congestive heart failure. J Am Coll Cardiol 1994;24:132-9.
37. 37. Werner GS, Schaefer C, Dirks R, et al. Doppler echocardiographic assessment of left ventricular filling in idiopathic dilated cardiomyopathy during a one-year follow-up: relation to the clinical course of disease. Am Heart J 1993;126:1408-16.
38. 38. Appleton CP, Hatle LK. The natural history of left ventricular filling abnormalities: assessment by two-dimensional and Doppler echocardiography. Echocardiography 1992;9:437-57.
39. 39. Pfeffer MA, Braunwald E, Moye LA, on behalf of the SAVE investigators. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669-77.